The sclerostin-bone protein interactome

被引:33
作者
Devarajan-Ketha, Hemamalini [1 ]
Craig, Theodore A. [1 ]
Madden, Benjamin J. [3 ]
Bergen, H. Robert, III [2 ,3 ]
Kumar, Rajiv [1 ,2 ]
机构
[1] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN 55905 USA
关键词
Sclerostin; Protein interaction; Protein affinity chromatography; Bone formation; Bone resorption; CARBONIC-ANHYDRASE; STATISTICAL-MODEL; SOST GENE; WNT; BMP; RECEPTOR; MASS; DELETION; DENSITY; KINASE;
D O I
10.1016/j.bbrc.2011.12.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The secreted glycoprotein, sclerostin alters bone formation. To gain insights into the mechanism of action of sclerostin, we examined the interactions of sclerostin with bone proteins using a sclerostin affinity capture technique. Proteins from decalcified rat bone were captured on a sclerostin-maltose binding protein (MOP) amylose column, or on a MBP amylose column. The columns were extensively washed with low ionic strength buffer, and bound proteins were eluted with buffer containing 1 M sodium chloride. Eluted proteins were separated by denaturing sodium-dodecyl sulfate gel electrophoresis and were identified by mass spectrometry. Several previously unidentified full-length sclerostin-interacting proteins such as alkaline phosphatase, carbonic anhydrase, gremlin-1, fetuin A, midkine, annexin A1 and A2, and collagen alpha 1, which have established roles in bone formation or resorption processes, were bound to the sclerostin-MBP amylose resin but not to the MBP amylose resin. Other full-length sclerostin-interacting proteins such as casein kinase II and secreted frizzled related protein 4 that modulate Wnt signaling were identified. Several peptides derived from proteins such as Phex, asporin and follistatin that regulate bone metabolism also bound sclerostin. Sclerostin interacts with multiple proteins that alter bone formation and resorption and is likely to function by altering several biologically relevant pathways in bone. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:830 / 835
页数:6
相关论文
共 52 条
[1]   Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism [J].
Atkins, Gerald J. ;
Rowe, Peter S. ;
Lim, Hui P. ;
Welldon, Katie J. ;
Ormsby, Renee ;
Wijenayaka, Asiri R. ;
Zelenchuk, Lesya ;
Evdokiou, Andreas ;
Findlay, David M. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1425-1436
[2]  
Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
[3]   Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease [J].
Balemans, W ;
Patel, N ;
Ebeling, M ;
Van Hul, E ;
Wuyts, W ;
Lacza, C ;
Dioszegi, M ;
Dikkers, FG ;
Hildering, P ;
Willems, PJ ;
Verheij, JBGM ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) :91-97
[4]   Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[5]   The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations [J].
Balemans, Wendy ;
Piters, Elke ;
Cleiren, Erna ;
Ai, Minrong ;
Van Wesenbeeck, Liesbeth ;
Warman, Matthew L. ;
Van Hul, Wim .
CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (06) :445-453
[6]   Osteogenesis imperfecta: Recent findings shed new light on this once well-understood condition [J].
Basel, Donald ;
Steiner, Robert D. .
GENETICS IN MEDICINE, 2009, 11 (06) :375-385
[7]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[8]   Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia [J].
Bragdon, Beth ;
Thinakaran, Shayamala ;
Moseychuk, Oleksandra ;
Gurski, Lauren ;
Bonor, Jeremy ;
Price, Christopher ;
Wang, Liyun ;
Beamer, Wesley G. ;
Nohe, Anja .
BONE, 2011, 49 (05) :944-954
[9]   Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein [J].
Brunkow, ME ;
Gardner, JC ;
Van Ness, J ;
Paeper, BW ;
Kovacevich, BR ;
Proll, S ;
Skonier, JE ;
Zhao, L ;
Sabo, PJ ;
Fu, YH ;
Alisch, RS ;
Gillett, L ;
Colbert, T ;
Tacconi, P ;
Galas, D ;
Hamersma, H ;
Beighton, P ;
Mulligan, JT .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :577-589
[10]   Cutting edge: Bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with slits and act as negative regulators of monocyte chemotaxis [J].
Chen, B ;
Blair, DG ;
Plisov, S ;
Vasiliev, G ;
Perantoni, AO ;
Chen, Q ;
Athanasiou, M ;
Wu, JY ;
Oppenheim, JJ ;
Yang, D .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :5914-5917